Anticancer therapy-induced adverse events: practicing damage control

Author： Lacouture Mario E   Lenihan Daniel   Wu Shenhong  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.11, Iss.1, 2012-05, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rasburicase: A Review of its Use in the Management of Anticancer Therapy-Induced Hyperuricaemia

By Oldfield Vicki   Perry Caroline M.  

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 529-545

Adis International

Access to resources Recommend Favorite

Palifermin: In Myelotoxic Therapy-Induced Oral Mucositis

By Siddiqui M. Asif A.   Wellington Keri  

Drugs, Vol. 65, Iss. 15, 2005-01 ,pp. : 2139-2146

Adis International

Access to resources Recommend Favorite

Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse Events

By Clark Rebecca  

Drug Safety, Vol. 28, Iss. 12, 2005-01 ,pp. : 1075-1083

Adis International

Access to resources Recommend Favorite

Risk of Adverse Events with the Use of Augmentation Therapy for the Treatment of Resistant Depression

By Schweitzer I.   Tuckwell V.  

Drug Safety, Vol. 19, Iss. 6, 1998-12 ,pp. : 455-464

Adis International

Access to resources Recommend Favorite

Potential for modest differences between sexes in antiretroviral therapy pharmacokinetics and adverse events

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 11, 2006-11 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite